AstraZeneca PLC American Depositary Shares (AZN)
NASDAQ (NGS) NASDAQ (NGS) Primary 
AstraZeneca is the latest major drugmaker to strike a deal with the Trump administration on lowering U.S. drug prices, according to a person familiar with the matter
The agreement follows last week's deal with Pfizer.
AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.
AstraZeneca PLC looks poised to announce a deal with U.S. President Donald Trump that's focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer Inc.
Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports
The Trump administration and AstraZeneca have reached an agreement for the U.K.-based pharmaceutical giant to cut drug prices in the U.S., MSNBC reported. President Donald Trump has already agreed to a similar pact with Pfizer, which will sell discounted drugs to Medicaid patients through a website called TrumpRx.gov.
AstraZeneca's baxdrostat hits key goal in major blood pressure trial
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) said its experimental drug baxdrostat met the main target in a late-stage study for patients with resistant hypertension. Specifically, it showed a “statistically significant and highly clinically meaningful” reduction in blood pressure compared with a placebo.
AstraZeneca's Baxdrostat meets main goal in high blood pressure study
AstraZeneca said on Tuesday its drug Baxdrostat met the main goal in a late-stage study in patients with treatment-resistant high blood pressure, or hypertension.
AstraZeneca's Datroway boosts survival in advanced breast cancer trial
AstraZeneca said on Monday its precision drug Datroway improved overall survival and progression free survival in patients with an advanced form of breast cancer versus chemotherapy in a trial when given early during treatment.
Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AstraZeneca shares leap with FDA set to review drug to treat breast cancer
AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.
AstraZeneca and other UK pharma boosted by Trump's first drug discount deal with Pfizer
Shares in the UK's biggest drug companies led the way on Wednesday, following news overnight that the US government had agreed its first deal on "most favoured nation" drug pricing with Pfizer. Topping the FTSE 100, Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares jumped 4% in early trading, with AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) and GSK PLC (LSE:GSK, NYSE:GSK) rising 3.6% and 1.4%.
CNBC's UK Exchange newsletter: AstraZeneca gets a shot on Wall Street
AstraZeneca is delisting its American Depositary Receipts from the Nasdaq, replacing them with a direct listing of ordinary shares on the New York Stock Exchange. At first blush, it confirms fears first aired when, in July, The Times reported that CEO Pascal Soriot wanted to move AZ's stock market listing to the U.S.
AstraZeneca's US listing may pull other firms from London in its wake
AstraZeneca's move to upgrade its listing in the U.S. risks pulling liquidity away from London's stock market and could pave the way for other large companies to follow suit, analysts, investors and advisers said.
AstraZeneca to directly list shares in New York, retain UK listing
AstraZeneca said on Monday that it will now directly list its shares on the New York Stock Exchange, instead of the current depository shares, adding that it will continue to be listed and headquartered in the UK.
